Rheumatology

REACH is an experienced thought leader in the rheumatology space. Our team has conducted research across many rheumatological diseases, both rare and non-rare.

DISEASES WE COVER

Rheumatology has evolved from a therapeutic area with poor remission rates and reliance on broadly immunosuppressive treatment to approval of many targeted agents. Current rheumatology dynamics the REACH team is tracking include:

  • First approvals in difficult to treat rheumatological conditions (e.g., Amgen’s Tavneos in GPA/MPA)
  • Potential future approvals for groundbreaking technologies (e.g., Adipose-Derived Regenerative Cell Therapy for scleroderma and CAR T cell therapy for SLE)
  • Increasing familiarity with and utilization of biosimilars
See our rare rheumatology solutions

Search Rheumatology diseases we cover

Disease
Adult-Onset Still's Disease
Adult-Onset Still's Disease
Ankylosing Spondylitis
Ankylosing Spondylitis
Auto-Antibody-Associated Vasculitis
Auto-Antibody-Associated Vasculitis
Behçet’s Disease
Behçet’s Disease
Giant Cell Arteritis
Giant Cell Arteritis
Gout
Gout
Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
Leukocytoclastic Vasculitis
Leukocytoclastic Vasculitis
Limited Cutaneous Systemic Sclerosis / CREST Syndrome
Limited Cutaneous Systemic Sclerosis / CREST Syndrome
Palindromic Rheumatism
Palindromic Rheumatism
Polyarteritis Nodosa
Polyarteritis Nodosa
Polymyalgia Rheumatica
Polymyalgia Rheumatica
Psoriatic Arthritis
Psoriatic Arthritis
Relapsing Polychondritis
Relapsing Polychondritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Sarcoidosis
Sarcoidosis
Scleroderma
Scleroderma
Sjögren’s Syndrome
Sjögren’s Syndrome
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Takayasu’s Arteritis
Takayasu’s Arteritis
Undifferentiated Connective Tissue Disease
Undifferentiated Connective Tissue Disease
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Disease
Adult-Onset Still's Disease
Adult-Onset Still's Disease
Ankylosing Spondylitis
Ankylosing Spondylitis
Auto-Antibody-Associated Vasculitis
Auto-Antibody-Associated Vasculitis
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Browse contacts:
1 2 3 … 7

Schedule a rheumatology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare rheumatology market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare rheumatological conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any rheumatology disease allow easy comparison across the rheumatology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for rheumatologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us